We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Plant-Derived Bioactive Compounds for Rhabdomyosarcoma Therapy In Vitro: A Systematic Review.
- Authors
Mesas, Cristina; Segura, Beatriz; Perazzoli, Gloria; Chico, Maria Angeles; Moreno, Javier; Doello, Kevin; Prados, Jose; Melguizo, Consolación
- Abstract
Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, constitutes approximately 40% of all recorded soft tissue tumors and is associated with a poor prognosis, with survival rates of less than 20% at 3 years. The development of resistance to cytotoxic drugs is a primary contributor to therapeutic failure. Consequently, the exploration of new therapeutic strategies is of vital importance. The potential use of plant extracts and their bioactive compounds emerges as a complementary treatment for this type of cancer. This systematic review focuses on research related to plant extracts or isolated bioactive compounds exhibiting antitumor activity against RMS cells. Literature searches were conducted in PubMed, Scopus, Cochrane, and WOS. A total of 173 articles published to date were identified, although only 40 were finally included to meet the inclusion criteria. Furthermore, many of these compounds are readily available and have reduced cytotoxicity, showing an apoptosis-mediated mechanism of action to induce tumor cell death. Interestingly, their use combined with chemotherapy or loaded with nanoparticles achieves better results by reducing toxicity and/or facilitating entry into tumor cells. Future in vivo studies will be necessary to verify the utility of these natural compounds as a therapeutic tool for RMS.
- Subjects
RHABDOMYOSARCOMA; BIOACTIVE compounds; SOFT tissue tumors; SARCOMA; PLANT extracts; SURVIVAL analysis (Biometry); ONE-way analysis of variance
- Publication
Applied Sciences (2076-3417), 2023, Vol 13, Issue 23, p12964
- ISSN
2076-3417
- Publication type
Article
- DOI
10.3390/app132312964